DHR vs PANW: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Palo Alto Networks, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
VS
Palo Alto Networks, Inc. · Technology
$287.78
+2.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+8.9%).
DHR trades at a lower forward P/E
(34.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
PANW |
| Current Price |
$177.17 |
$287.78 |
| Fair Value Estimate |
$192.90 |
$296.19 |
| Upside to Fair Value |
+8.9%
|
+2.9%
|
| Market Cap |
$125.4B |
$196.1B |
| Forward P/E |
34.1x
|
248.9x
|
| EV / EBITDA |
20.8x
|
85.9x
|
| Price / Sales |
5.1x
|
18.5x
|
| Price / FCF |
23.7x
|
45.7x
|
| Revenue Growth YoY |
+3.7%
|
+31.1%
|
| Gross Margin |
60.7%
|
71.9%
|
| Operating Margin |
21.0%
|
9.6%
|
| Return on Equity |
7.1%
|
6.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.22%
|
2.19%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Palo Alto Networks is a leading cybersecurity company specializing in next-generation security platforms with a strong subscription and support revenue base comprising approximately 81% of total revenue. The company benefits from a wide and expanding competitive moat driven by its AI- and platform-driven cybersecurity solutions, led by a seasoned management team. Despite strong revenue growth of …
Accumulation Zones
| Metric |
DHR |
PANW |
| Zone Low |
$144.68 |
$222.14 |
| Zone High |
$163.97 |
$251.76 |
| In Buy Zone? |
No
|
No
|